Lp. Dwoskin et al., Acute and chronic effects of nornicotine on locomotor activity in rats: altered response to nicotine, PSYCHOPHAR, 145(4), 1999, pp. 442-451
Rationale: Nicotine, a tobacco alkaloid, is known to be important in the ac
quisition and maintenance of tobacco smoking. Nornicotine, an active nicoti
ne metabolite, stimulates nicotinic receptors and may produce psychomotor e
ffects similar to nicotine. Objective: The present study determined the eff
ects of acute and repeated administration of nornicotine on locomotor activ
ity and compared its effects with those of nicotine. Methods: R(+)-Nornicot
ine (0.3-10 mg/kg), S(-)-nornicotine (0.3-10 mg/kg), S(-)-nicotine (0.1-1 m
g/kg) or saline was administered s.c, to rats acutely or repeatedly (eight
injections at 48-h intervals). Activity was recorded for 50 min immediately
after each injection. Results: S(-)-Nicotine produced transient hypoactivi
ty, followed by dose-related hyperactivity. Repeated S(-)-nicotine administ
ration resulted in tolerance to the hypoactivity and sensitization to the h
yperactivity. Subsequent testing following a saline injection revealed evid
ence of conditioned hyperactivity. Acute administration of 0.3 mg/kg or 1 m
g/kg R(+)- or S(-)-nornicotine produced no effect. Transient hypoactivity w
as observed at 3 mg/kg and 10 mg/kg R(+)-nornicotine and at 10 mg/kg S(-)-n
ornicotine. However, rebound hyperactivity was not observed following acute
administration of either nornicotine enantiomer, suggesting that nornicoti
ne-induced psychomotor effects differ qualitatively from those of S(-)-nico
tine. Repeated R(+)-nornicotine resulted in tolerance to the transient hypo
activity, however hyperactivity was not observed. Repeated S(-)-nornicotine
resulted in tolerance to the hypoactivity and the appearance of hyperactiv
ity. Repeated administration of either nornicotine enantiomer resulted in a
dose-dependent alteration in response to a 1 mg/kg S(-)-nicotine challenge
, suggesting some commonalities in the mechanism of action. Conclusion: Nor
nicotine likely contributes to the neuropharmacological effects of nicotine
and tobacco use.